Medical Oncology for NEET-SS
Overview
Medical Oncology is a super-speciality built on a very wide base. A medical oncologist must understand cancer biology, interpret pathology and imaging, choose among chemotherapy, targeted therapy, immunotherapy and hormonal treatment, and manage the complications of both disease and treatment. For NEET-SS, questions draw on the feeder syllabus but are framed at exit level: the examiner wants the stage-based decision, the named regimen or the correct toxicity rather than a textbook definition.
This page outlines the high-yield areas, a study approach and a revision plan. For the current pattern and eligibility, refer to the latest NBEMS information bulletin.
Why this subject matters (in the exam)
Oncology questions tend to test decisions rather than isolated facts. A single stem may give a histology, a molecular result and a performance status, then ask for the most appropriate first-line treatment. Another may describe a patient on treatment with fever or a biochemical derangement and ask for the emergency or the drug responsible.
The subject also rewards integration, since pathology, pharmacology, haematology, radiology and palliative care all meet here. Learning by disease, stage and treatment logic lets you reason out many answers that rote regimen lists cannot. Because standards of care keep changing, the exam favours well-established, widely accepted practice over very recent or experimental data.
High-yield topics
- Principles and biology: hallmarks of cancer, oncogenes and tumour suppressor genes, the cell cycle and cell-cycle-specific drugs, drug resistance.
- Prevention and genetics: common cancers in India, tobacco and areca nut as risk factors, screening for breast, cervical, colorectal and oral cancer, and hereditary syndromes such as BRCA-related cancers, Lynch syndrome, Li-Fraumeni syndrome and familial adenomatous polyposis.
- Diagnosis and staging: the TNM concept, appropriate use of tumour markers and PET-CT, immunohistochemistry and molecular testing (EGFR, ALK, HER2, KRAS, BRAF, microsatellite instability).
- Breast and lung cancer: receptor-based breast subtypes, endocrine and HER2-directed therapy; small-cell versus non-small-cell lung cancer, driver mutations with matched targeted agents, immunotherapy basics.
- Gastrointestinal cancers: colorectal staging and adjuvant therapy, gastric, oesophageal, gallbladder, pancreatic and hepatocellular carcinoma, neuroendocrine tumours, GIST and imatinib.
- Genitourinary and gynaecological cancers: prostate, bladder and renal cell carcinoma, germ cell tumours with their markers, ovarian and cervical cancers, gestational trophoblastic disease.
- Head and neck cancers: the oral cancer burden in India, chemoradiation principles, nasopharyngeal and thyroid cancers.
- Haematological malignancies: acute and chronic leukaemias (including acute promyelocytic leukaemia and imatinib in chronic myeloid leukaemia), Hodgkin and non-Hodgkin lymphomas, multiple myeloma, myelodysplastic and myeloproliferative neoplasms.
- Paediatric and sarcoma oncology: Wilms tumour, neuroblastoma, retinoblastoma, osteosarcoma, Ewing sarcoma, soft tissue sarcomas.
- Systemic therapy pharmacology: signature toxicities of cisplatin, doxorubicin, bleomycin, vincristine and methotrexate, rescue strategies, targeted agent class effects, immune checkpoint inhibitors and immune-related adverse events.
- Oncologic emergencies: febrile neutropenia, tumour lysis syndrome, superior vena cava syndrome, spinal cord compression, hypercalcaemia of malignancy, SIADH.
- Supportive and palliative care: antiemetic strategy, growth factors, pain ladder and opioid use, cachexia, bone-modifying agents, end-of-life communication.
- Radiotherapy and transplantation basics: common radiation toxicities and indications for stem cell transplantation.
How to study this subject
Begin with principles, because they make the rest easier. Understand how the cell cycle, mechanisms of action and resistance explain why drugs are combined and why toxicities cluster by class. Then move to diseases, following a fixed template for each cancer: risk factors, pathology and molecular markers, staging, treatment by stage, important toxicities and follow-up.
Keep a one-page drug table of mechanism, indication and signature toxicity. Study staging and treatment together, since the stem often hides the answer in the stage. Read the main recommendations of widely used guidelines for common cancers. Practise clinical vignettes early, and trace every error back to its concept.
Revision strategy
Oncology holds many small, specific facts, so revision must be compact and frequent. Convert notes into tables covering drugs and toxicities, tumour markers, genetic syndromes, paraneoplastic syndromes, and targeted agents with their targets. Revise these weekly.
Maintain an error log grouped by disease site and question type, such as regimen choice, toxicity, staging or emergency, and revisit it every fortnight. Give shorter cycles to common cancers and emergencies. In the final weeks, alternate timed mocks with focused review of weak areas, and finish with a rapid pass through your tables.
Preparation with PrepElephant
The PrepElephant app offers topic-wise question practice, a structured question bank and exam-format mock tests for NEET-SS, along with revision tools that keep your flagged questions and error-log concepts in rotation. Practice material supports your reading and does not replace a standard textbook or clinical exposure.
All Medical Oncology topics for NEET-SS 27
C
H
P
S
Frequently asked questions
Is Medical Oncology only about chemotherapy drugs?
No. Drugs are important, but questions also test staging, molecular diagnostics, screening, genetic syndromes, emergencies and palliative principles.
How should I handle the rapid changes in oncology guidelines?
Prioritise established, widely adopted standards for the common cancers and learn the reasoning behind them. Very recent data is less likely to be the sole basis of an answer.
Which oncologic emergencies should I know best?
Febrile neutropenia, tumour lysis syndrome, superior vena cava syndrome, spinal cord compression and hypercalcaemia of malignancy are the usual priorities. For each, know the recognition, the immediate step and prevention.
What is the best way to remember drug toxicities?
Group drugs by class and link each signature toxicity to its mechanism, such as cumulative cardiotoxicity with anthracyclines or pulmonary fibrosis with bleomycin. Revise one compact table repeatedly instead of rereading long notes.
Where can I find the current NEET-SS pattern and eligibility?
The official NBEMS information bulletin for the current cycle gives the pattern, eligibility, marking scheme and qualifying criteria. Details can change between cycles, so confirm them there.
Practise this in the PrepElephant app
Question banks, previous-year questions, mock tests and revision tools — for Medical Oncology for NEET-SS. Free to start.